trending Market Intelligence /marketintelligence/en/news-insights/trending/h4dwj_m7rm5mt1ue6paxpq2 content esgSubNav
In This List

Celgene starts $5B share repurchase program

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Celgene starts $5B share repurchase program

New Jersey-based Celgene Corp.'s board has authorized a $5 billion share repurchase program, effective Feb. 14.

The buybacks can be made in the open market or in privately negotiated deals from time to time, as determined by Celgene's management and in accordance with the SEC's requirements.